U.S. flag

An official website of the United States government

NM_022124.6(CDH23):c.8391C>A (p.Ala2797=) AND not provided

Germline classification:
Likely benign (1 submission)
Last evaluated:
Jan 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003709275.2

Allele description [Variation Report for NM_022124.6(CDH23):c.8391C>A (p.Ala2797=)]

NM_022124.6(CDH23):c.8391C>A (p.Ala2797=)

Gene:
CDH23:cadherin related 23 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q22.1
Genomic location:
Preferred name:
NM_022124.6(CDH23):c.8391C>A (p.Ala2797=)
HGVS:
  • NC_000010.11:g.71807598C>A
  • NG_008835.1:g.415652C>A
  • NM_001171933.1:c.1671C>A
  • NM_001171934.1:c.1671C>A
  • NM_022124.6:c.8391C>AMANE SELECT
  • NP_001165404.1:p.Ala557=
  • NP_001165405.1:p.Ala557=
  • NP_071407.4:p.Ala2797=
  • NC_000010.10:g.73567355C>A
Molecular consequence:
  • NM_001171933.1:c.1671C>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001171934.1:c.1671C>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_022124.6:c.8391C>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

  • Tssr13125 AND (alive[prop]) (0)
    Gene
  • Medicaid
    Medicaid
    Federal program, created by Public Law 89-97, Title XIX, a 1965 amendment to the Social Security Act, administered by the states, that provides health care benefits to indigen...<br/>Year introduced: 1991
    MeSH
  • Medicare Part C
    Medicare Part C
    The Balanced Budget Act (BBA) of 1997 establishes a Medicare+Choice program under part C of Title XVIII, Section 4001, of the Social Security Act. Under this program, an eligi...<br/>Year introduced: 1999
    MeSH
  • Medical Device Legislation
    Medical Device Legislation
    Laws, statutes, and regulations pertaining to devices used in medicine.<br/>Year introduced: 2013
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004487043Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely benign
(Jan 13, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004487043.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024